Us District Court

A federal judge on Wednesday ruled against US health insurer Anthem Inc's proposed USD 54 billion merger with smaller rival Cigna Corp, derailing an unprecedented effort to consolidate the country‘s health insurance industry.

US Court rules in favour of Mylan for Copaxone patents: Natco

"The United States District Court for the District of Delaware issued a decision finding all asserted claims of four Orange Book-listed patents related to Copaxone 40 mg/mL invalid based on obviousness," Natco Pharma said in a BSE filing.

US: Class action lawsuits filed against textile maker Welspun

The lawsuit has been filed in the US District Court in the Southern District of New York by Meghan Abbott, a North Carolina resident who purchased bed linens by Welspun from retail store Target.

Bosch concealed VW use of 'defeat device' software: Lawyers

The filing on Friday in US District Court in San Francisco expands on claims plaintiffs lawyers made in August, when they alleged Bosch was a "knowing and active participant" in Volkswagen's decade-long scheme to evade U.S. anti-pollution laws. Bosch lawyers said last month those claims were "wild and unfounded."

US industry bodies sue over Obama corporate tax rules

In a rule adopted in April, the US Treasury sought to prevent American companies from moving overseas to reduce their tax burdens, often through reverse mergers.

Adidas sues Skechers, claiming 'Springblade' shoe knockoff

In a complaint filed in US District Court in Portland, Oregon, Adidas said Skechers willfully infringed two patents related to Springblade, a three-year-old design whose midsole includes blades meant to help propel runners forward.

Alibaba win dismissal of lawsuit over pre IPO regulatory warning

Chief Judge Colleen McMahon of the US District Court in Manhattan ruled late Tuesday that Alibaba did not fraudulently omit its July 16, 2014 meeting with China's powerful State Administration for Industry and Commerce from investor materials for its USD 25 billion initial public offering two months later.

US court releases JSW Steel from further liability to MM Steel

"On June 16, 2016, the district court entered an order releasing JSW Steel USA INC from any further liability to MM Steel under the judgment in return for a payment of USD 5,48,52,478.24," JSW Steel said in a BSE filing.

Dr Reddy's settles patent litigation on Kuvan tablets

According to a statement issued by BioMarin, the US drugmaker said it will grant Dr Reddy's a non-exclusive licence to its patents on Kuvan (sapropterin dihydrochloride) allowing the Indian drug maker to market a generic version of Kuvan 100mg tablets in the US at a later stage, which is expected to be more than five years from now.

Barclays must face US class action over Libor

US District Judge Shira Scheindlin in Manhattan, whose May 2013 dismissal of the case was overturned by an appeals court, said the claims were similar enough to justify letting the shareholders sue as a group.

US jury orders Motorola Mobility to pay $10 mn in Fujifilm

Fujifilm Corp, a subsidiary of Tokyo-based Fujifilm Holdings Corp, sued Motorola in 2012, accusing the company of infringing three of its patents on digital camera functions and a fourth patent relating to transmitting data over a wireless connection such as Bluetooth.

Ralph Lauren to get $3.2 mn from Arvind in settlement

The Club Monaco and Polo Ralph Lauren maker had filed a case in a US District Court against Arvind Lifestyle and US Polo Association (USPA), alleging a breach of agreement regarding disclaimers to be printed on USPA products sold in India.

Apple ordered to pay $533 million for patent infringement

Though Smartflash had been asking for USD 852 million in damages, the verdict, which came late Tuesday night, was still a costly blow for the US tech giant, the most valuable company in the world.

Ranbaxy sues USFDA; US Court to hear motion

USFDA had revoked tentative approvals granted to Ranbaxy for generic versions of two drugs - AstraZeneca's heartburn drug Nexium & Roche's antiviral drug Valcyte.

Samsung ends patent row with Ericsson; to pay over $650 m

Ericsson and Samsung have reached an agreement on global patent licences between the two companies relating to GSM, UMTS, and LTE standards for both networks and handsets.

US seeks $864 mn from Bank of America after fraud verdict

The government said the penalties were necessary to punish the bank and Mairone "and to send a clear and unambiguous message that mortgage fraud for profit will not be tolerated."

JPMorgan in $23 mn settlement with clients over Lehman

The largest US bank denied wrongdoing in agreeing to settle, and entered the settlement solely to eliminate the burden and cost of litigation

Goldman cleared of all charges in doomed Dragon sale

A federal jury on Wednesday gave Goldman Sachs Group Inc a sweeping legal victory in the USD 580 million sale of Dragon Systems Inc to Lernout & Hauspie, saying the Wall Street bank was not negligent in arranging a deal that ultimately collapsed 13 years ago.

Infosys says US investigating visa sponsorships

Infosys, India's No. 2 software services provider, said it was being investigated in Texas over its sponsorship and use of US business visas.

Will file appeal in US court on drug patent breach: Cipla

A US District Court has ordered the seizure of a drug made by Cipla and sold by Velecra. S Radhakrishnan, CFO, Cipla has clarified on CNBC-TV18 that they are in process of filing an appeal within the next 60 days.

Got subpoena from US court on visas: Infosys

Indian software services exporter Infosys Technologies said on Tuesday it received a subpoena from a grand jury in a US district court that requires the company to provide certain documents and records related to B1 business visas.

Gilead, Roche's suit on expected lines: Natco Pharma

In an interview with CNBC-TV18, Bhaskar Narayana, Finance Director & CFO, Natco Pharma said," In a patently challenged issue, the innovator is bound to protect his rights and this can be done only through the mechanism of suing.There is nothing extra-ordinary about it."

Dr Reddy's says US court clears generic Allegra sale

Number 2 drugmaker Dr Reddy's Laboratories Ltd said on Monday a US district court has cleared the sale of its generic version of Sanofi-Aventis' allergy treatment drug Allegra D24.